Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al. Tonin P, et al. Among authors: krainer m. Nat Med. 1996 Nov;2(11):1179-83. doi: 10.1038/nm1196-1179. Nat Med. 1996. PMID: 8898735 Review. No abstract available.
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA. FitzGerald MG, et al. Among authors: krainer m. N Engl J Med. 1996 Jan 18;334(3):143-9. doi: 10.1056/NEJM199601183340302. N Engl J Med. 1996. PMID: 8531968 Free article.
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA. Krainer M, et al. N Engl J Med. 1997 May 15;336(20):1416-21. doi: 10.1056/NEJM199705153362003. N Engl J Med. 1997. PMID: 9145678 Free article.
Common nonsense mutations in RAD52.
Bell DW, Wahrer DC, Kang DH, MacMahon MS, FitzGerald MG, Ishioka C, Isselbacher KJ, Krainer M, Haber DA. Bell DW, et al. Among authors: krainer m. Cancer Res. 1999 Aug 15;59(16):3883-8. Cancer Res. 1999. PMID: 10463575
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.
Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA. Nichols KE, et al. Among authors: krainer m. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13765-70. doi: 10.1073/pnas.95.23.13765. Proc Natl Acad Sci U S A. 1998. PMID: 9811875 Free PMC article.
Increased survival with enzalutamide in prostate cancer after chemotherapy.
Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Fléchon A, Mainwaring P, Fleming M, Hainsworth JD, Hirmand M, Selby B, Seely L, de Bono JS; AFFIRM Investigators. Scher HI, et al. N Engl J Med. 2012 Sep 27;367(13):1187-97. doi: 10.1056/NEJMoa1207506. Epub 2012 Aug 15. N Engl J Med. 2012. PMID: 22894553 Free article. Clinical Trial.
Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L, Ryser S, Dizin E, Pils D, Krainer M, Jefford CE, Bertoni F, Zeillinger R, Irminger-Finger I. Li L, et al. Among authors: krainer m. Cancer Res. 2007 Dec 15;67(24):11876-85. doi: 10.1158/0008-5472.CAN-07-2370. Cancer Res. 2007. PMID: 18089818
117 results